<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">34323</article-id><article-id pub-id-type="doi">10.7554/eLife.34323</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>VEGF-C promotes the development of lymphatics in bone and bone loss</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-103813"><name><surname>Hominick</surname><given-names>Devon</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-103814"><name><surname>Silva</surname><given-names>Asitha</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-103815"><name><surname>Khurana</surname><given-names>Noor</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-103816"><name><surname>Liu</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-103817"><name><surname>Dechow</surname><given-names>Paul C</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-103818"><name><surname>Feng</surname><given-names>Jian Q</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-103819"><name><surname>Pytowski</surname><given-names>Bronislaw</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-103820"><name><surname>Rutkowski</surname><given-names>Joseph M</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10948"><name><surname>Alitalo</surname><given-names>Kari</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" corresp="yes" id="author-102943"><name><surname>Dellinger</surname><given-names>Michael T</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3315-4239</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Hamon Center for Therapeutic Oncology Research</institution>, <institution>UT Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Biomedical Sciences</institution>, <institution>Texas A&amp;M College of Dentistry</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution>Eli Lilly and Company</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Medical Physiology</institution>, <institution>Texas A&amp;M College of Medicine</institution>, <addr-line><named-content content-type="city">College Station</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Wihuri Research Institute</institution>, <institution>University of Helsinki</institution>, <addr-line><named-content content-type="city">Helsinki</named-content></addr-line>, <country>Finland</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-31389"><name><surname>Gerhardt</surname><given-names>Holger</given-names></name><role>Reviewing editor</role><aff><institution>Max Delbrück Centre for Molecular Medicine</institution>, <country>Germany</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>bronek.pytowski@gmail.com</email> (BP);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>michael.dellinger@utsouthwestern.edu</email> (MD);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>05</day><month>04</month><year>2018</year></pub-date><volume>7</volume><elocation-id>e34323</elocation-id><history><date date-type="received"><day>13</day><month>12</month><year>2017</year></date><date date-type="accepted"><day>22</day><month>03</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Hominick et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Hominick et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-34323-v1.pdf"/><abstract><p>Patients with Gorham-Stout disease (GSD) have lymphatic vessels in their bones and their bones gradually disappear. Here we report that mice that overexpress VEGF-C in bone exhibit a phenotype that resembles GSD. To drive VEGF-C expression in bone, we generated <italic>Osx-tTA;TetO-Vegfc</italic> double-transgenic mice. In contrast to <italic>Osx-tTA</italic> mice, <italic>Osx-tTA;TetO-Vegfc</italic> mice developed lymphatics in their bones. We found that inhibition of VEGFR3, but not VEGFR2, prevented the formation of bone lymphatics in <italic>Osx-tTA;TetO-Vegfc</italic> mice. Radiological and histological analysis revealed that bones from <italic>Osx-tTA;TetO-Vegfc</italic> mice were more porous and had more osteoclasts than bones from <italic>Osx-tTA</italic> mice. Importantly, we found that bone loss in <italic>Osx-tTA;TetO-Vegfc</italic> mice could be attenuated by an osteoclast inhibitor. We also discovered that the mutant phenotype of <italic>Osx-tTA;TetO-Vegfc</italic> mice could be reversed by inhibiting the expression of VEGF-C. Taken together, our results indicate that expression of VEGF-C in bone is sufficient to induce the pathologic hallmarks of GSD in mice.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>The Lymphatic Malformation Institute</institution></institution-wrap></funding-source><award-id>Research Grant</award-id><principal-award-recipient><name><surname>Dellinger</surname><given-names>Michael T</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Bronislaw Pytowski, During preparation of the manuscript, B. Pytowski was an employee of Eli Lilly and continues to hold stock in the company.</p></fn><fn fn-type="conflict" id="conf3"><p>Kari Alitalo, Reviewing editor, eLife.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: The animal experiments described in this manuscript were carried out in accordance with animal protocols (2014-0031 and 2016-101510) approved by the Institutional Animal Care and Use Committee of UT Southwestern Medical Center.</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-34323-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>